176 related articles for article (PubMed ID: 32427884)
1. Critical role of SOX2-IGF2 signaling in aggressiveness of bladder cancer.
Chiu YF; Wu CC; Kuo MH; Miao CC; Zheng MY; Chen PY; Lin SC; Chang JL; Wang YH; Chou YT
Sci Rep; 2020 May; 10(1):8261. PubMed ID: 32427884
[TBL] [Abstract][Full Text] [Related]
2. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway.
Tian B; Zhao Y; Liang T; Ye X; Li Z; Yan D; Fu Q; Li Y
J Drug Target; 2017 Aug; 25(7):626-636. PubMed ID: 28286973
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
Huang GS; Brouwer-Visser J; Ramirez MJ; Kim CH; Hebert TM; Lin J; Arias-Pulido H; Qualls CR; Prossnitz ER; Goldberg GL; Smith HO; Horwitz SB
Clin Cancer Res; 2010 Jun; 16(11):2999-3010. PubMed ID: 20404007
[TBL] [Abstract][Full Text] [Related]
5. High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
Wang G; Huang Y; Yang F; Tian X; Wang K; Liu L; Fan Y; Li X; Li L; Shi B; Hao Y; Xia C; Nie Q; Xin Y; Shi Z; Ma L; Xu D; Liu C
Aging (Albany NY); 2020 Feb; 12(3):2030-2048. PubMed ID: 32007952
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X
Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 2 regulates the proliferation and differentiation of rat adipose-derived stromal cells via IGF-1R and IR.
Wang C; Li X; Dang H; Liu P; Zhang BO; Xu F
Cytotherapy; 2019 Jun; 21(6):619-630. PubMed ID: 30956007
[TBL] [Abstract][Full Text] [Related]
10. IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.
Neuzillet Y; Chapeaublanc E; Krucker C; De Koning L; Lebret T; Radvanyi F; Bernard-Pierrot I
BMC Cancer; 2017 Sep; 17(1):636. PubMed ID: 28882129
[TBL] [Abstract][Full Text] [Related]
11. Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4.
Malak PN; Dannenmann B; Hirth A; Rothfuss OC; Schulze-Osthoff K
Cell Cycle; 2015; 14(23):3748-54. PubMed ID: 26654770
[TBL] [Abstract][Full Text] [Related]
12. Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway.
Liu SB; Zhou LB; Wang HF; Li G; Xie QP; Hu B
Neoplasma; 2020 Jan; 67(1):129-136. PubMed ID: 31847523
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells.
Jeong CH; Cho YY; Kim MO; Kim SH; Cho EJ; Lee SY; Jeon YJ; Lee KY; Yao K; Keum YS; Bode AM; Dong Z
Stem Cells; 2010 Dec; 28(12):2141-50. PubMed ID: 20945330
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas.
Lin F; Shen Z; Xu X; Hu BB; Meerani S; Tang LN; Zheng SE; Sun YJ; Min DL; Yao Y
Int J Immunopathol Pharmacol; 2013; 26(1):169-77. PubMed ID: 23527719
[TBL] [Abstract][Full Text] [Related]
15. IGF-1 mediated Neurogenesis Involves a Novel RIT1/Akt/Sox2 Cascade.
Mir S; Cai W; Carlson SW; Saatman KE; Andres DA
Sci Rep; 2017 Jun; 7(1):3283. PubMed ID: 28607354
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
17. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.
Chou YT; Lee CC; Hsiao SH; Lin SE; Lin SC; Chung CH; Chung CH; Kao YR; Wang YH; Chen CT; Wei YH; Wu CW
Stem Cells; 2013 Dec; 31(12):2607-19. PubMed ID: 23940081
[TBL] [Abstract][Full Text] [Related]
19. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
[TBL] [Abstract][Full Text] [Related]
20. trans-10,cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells.
Jung JI; Cho HJ; Kim J; Kwon DY; Park JH
J Med Food; 2010 Feb; 13(1):13-9. PubMed ID: 20136431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
